In a recent genome-scale CRISPR screen, LKB1 was identified as a master regulator of chromatin accessibility in lung adenocarcinomas, and the loss of LKB1 activated SOX17 in metastasis and in a metastatic-like subpopulation of cancer cells within primary tumors [52]. The gene discussed is SOX17; the disease is cancer.